The current study has demonstrated that PSMA-based tracer PET/CT imaging seems to be a promising tool and shows clear superiority in the detection of PCa with BCR and PSA when compared to choline- and fluciclovine-based tracers. The gene discussed is PROS1; the disease is posterior cortical atrophy.